2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
21
Prostatic Neoplasms
7
Thyroid Nodule
4
Neoplasms
4
Liver Neoplasms
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Sarcopenia
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Mouth Neoplasms
3
Liver Cirrhosis
3
Endometrial Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Tongue Neoplasms
2
Thyroid Neoplasms
2
Postoperative Complications
2
Ovarian Cysts
2
Lung Neoplasms
2
Kidney Neoplasms
2
Hypersensitivity
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Interventions
Metformin
8
Progesterone
6
Spironolactone
4
drospirenone and ethinyl estradiol combination
3
Inositol
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
Sugars
2
Folic Acid
2
Flutamide
2
Estradiol
2
Cyproterone Acetate
2
Clomiphene
2
maltodextrin
1
licogliflozin
1
bicalutamide
1
Yoga
1
Waist-Hip Ratio
1
Waist Circumference
1
Ultrasonography
1
Topiramate
1
Time
1
Thioctic Acid
1
Sodium Salicylate
1
Sex Characteristics
1
Physical Examination
1
Phlebotomy
1
Phenotype
1
Ovidrel
1
Magnesium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hyperandrogenism
×
Ultrasonography
×
Clear all
NCT05926115
2023-07-03
PEP-Colombia
Instituto de fertilidad humana, InSer
Unknown
626 enrolled